Table 2.
2016 WHO diagnostic criteria for polycythaemia vera (PV)
| PV diagnosis requires meeting either all three major criteria or the first two major criteria and one minor criterion | |
| Major criteria | Hb >165g/L (men)/>160g/L (women) or HCT >49% (men)/>48% (women) or increased red cell mass more than 25% above mean normal predicted value |
| BM biopsy showing hypercellularity for age with trilineage growth including prominent erythroid, granulocytic and megakaryocytic proliferation with pleomorphic mature megakaryocytes (difference in size) | |
| Presence of JAK2 or JAK2 exon 12 mutation | |
| Minor criteria | Subnormal serum erythropoietin level |
| Criterion number 2 (BM biopsy) may not be required in cases with sustained absolute erythrocytosis: Hb levels 185g/L in men (HCT 55.5%) or 165g/L in women (HCT 49.5%) if major criterion 3 and the minor criterion are present. However, initial myelofibrosis (present in up to 20% of patients) can only be detected by performing a BM biopsy; this finding may predict a more rapid progression to overt myelofibrosis | |
BM, bone marrow; Hb, haemoglobin; HCT, haematocrit.